Jan Ravkilde

1991–2020 年に発表

40
論文数
18,639
被引用数
40
h 指数
40
i10 指数

被引用数

Jan Ravkilde の年別被引用数1987 年: 被引用 1 件1992 年: 被引用 4 件1993 年: 被引用 9 件1994 年: 被引用 10 件1995 年: 被引用 26 件1996 年: 被引用 34 件1997 年: 被引用 41 件1998 年: 被引用 29 件1999 年: 被引用 54 件2000 年: 被引用 69 件2001 年: 被引用 26 件2002 年: 被引用 33 件2003 年: 被引用 27 件2004 年: 被引用 41 件2005 年: 被引用 36 件2006 年: 被引用 31 件2007 年: 被引用 53 件2008 年: 被引用 79 件2009 年: 被引用 90 件2010 年: 被引用 125 件2011 年: 被引用 110 件2012 年: 被引用 121 件2013 年: 被引用 141 件2014 年: 被引用 143 件2015 年: 被引用 154 件2016 年: 被引用 167 件2017 年: 被引用 174 件2018 年: 被引用 142 件2019 年: 被引用 452 件2020 年: 被引用 416 件2021 年: 被引用 321 件2022 年: 被引用 211 件2023 年: 被引用 142 件2024 年: 被引用 198 件2025 年: 被引用 95 件2026 年: 被引用 3 件1988〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,155 件、この内訳の 17.1%イギリス: 引用元論文 557 件、この内訳の 8.2%ドイツ: 引用元論文 459 件、この内訳の 6.8%イタリア: 引用元論文 399 件、この内訳の 5.9%中国: 引用元論文 367 件、この内訳の 5.4%オランダ: 引用元論文 346 件、この内訳の 5.1%スペイン: 引用元論文 233 件、この内訳の 3.5%デンマーク: 引用元論文 229 件、この内訳の 3.4%スイス: 引用元論文 227 件、この内訳の 3.4%フランス: 引用元論文 226 件、この内訳の 3.3%カナダ: 引用元論文 217 件、この内訳の 3.2%スウェーデン: 引用元論文 174 件、この内訳の 2.6%
0%17.1%その他 32.1%

分野

  • Medicine87.1%
  • Biochemistry, Genetics and Molecular Biology6.6%
  • Engineering1.9%
  • Immunology and Microbiology1.3%
  • Materials Science0.5%
  • Neuroscience0.4%
  • その他2.2%

トピック

  • Acute Myocardial Infarction Research14.4%
  • Coronary Interventions and Diagnostics11.8%
  • Cardiac Imaging and Diagnostics11.3%
  • Antiplatelet Therapy and Cardiovascular Diseases2.7%
  • Cardiac, Anesthesia and Surgical Outcomes2.6%
  • Cardiac Ischemia and Reperfusion2.3%
  • その他54.9%

共著者

全論文

検索で開く
  1. Third Universal Definition of Myocardial Infarction

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William Wijns, Jean‐Pierre Bassand, P Menasché, Jan Ravkilde, E. Magnus Ohman, Elliott M. Antman, Lars Wallentin, Paul W. Armstrong, Maarten L. Simoons, James L. Januzzi, Markku S. Nieminen, Mihai Gheorghiade, Gerasimos Filippatos, Russell V. Luepker, Stephen P. Fortmann, Wayne D. Rosamond, Daniel Levy, David Wood, Sidney C. Smith, Dayi Hu, J L López-Sendón, Rose Marie Robertson, Douglas Weaver, Michał Tendera, Alfred A. Bové, Alexander Parkhomenko, Elena Vasilieva, Shanti Mendis - Journal of the American College of Cardiology 2012 被引用: 2,632

  2. Third universal definition of myocardial infarction

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barry F. Uretsky, Philippe Gabríel Steg, William Wijns, Jean‐Pierre Bassand, P Menasché, Jan Ravkilde, E. Magnus Ohman, Elliott M. Antman, Lars Wallentin, Paul W. Armstrong, Phillippe Menasché, James L. Januzzi, Markku S. Nieminen, Mihai Gheorghiade, Gerasimos Filippatos, Russell V. Luepker, Stephen P. Fortmann, Wayne D. Rosamond, Daniel Levy, David Wood, Sidney C. Smith, Dayi Hu, J L López-Sendón, Rose Marie Robertson, Dan Levy, Michał Tendera, Alfred A. Bové, Alexander Parkhomenko, Elena Vasilieva, Rose Marie Robertson, Jeroen J. Bax, Helmut Baumgartner, Claudio Ceconi, Verónica Dean, Christi Deaton, Robert Fagard, Christian Funck‐Brentano, David Hasdai, Arno W. Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Theresa A. McDonagh, David Hasdai, Bogdan A. Popescu, Željko Reiner, Udo Sechtem, Per Anton Sirnes, Michał Tendera, Adam Torbicki, Alec Vahanian, Stephan Windecker, Udo Sechtem, João Morais, Carlos Aguíar, Wael Almahmeed, Davíð O. Arnar, Fabio Barili, Kenneth D. Bloch, Ann F. Bolger, Hans Erik Bøtker, Biykem Bozkurt, Raffaele Bugiardini, Christopher P. Cannon, James A. de Lemos, Franz R. Eberli, Edgardo Escobar, Mark A. Hlatky, Stefan James, Karl B. Kern ほか 15 名 - European Heart Journal 2012 被引用: 3,068

  3. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , - The Lancet 2015 被引用: 966

  4. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan Ravkilde, Alisdair Ryding, Michael Rahbek Schmidt, Ingunn S. Riddervold, Henrik Toft Sørensen, Goran Stanković, Madhusudhan Varma, Ian Webb, Christian Juhl Terkelsen, John P. Greenwood, Derek M. Yellon, Hans Erik Bøtker, Anders Junker, Anne Kaltoft, Morten Madsen, Evald Høj Christiansen, Lars Jakobsen, Steen Carstensen, Steen Dalby Kristensen, Troels Thim, Karin Møller Pedersen, Mette Tidemand Korsgaard, Allan Iversen, Erik Jørgensen, Francis R. Joshi, Frants Pedersen, Hans Henrik Tilsted, Karam Alzuhairi, Kari Saunamäki, Lene Holmvang, Ole Ahlehof, Rikke Sørensen, Steffen Helqvist, B. Màrk, Anton Boel Villadsen, Bent Raungaard, Leif Thuesen, Martin Kirk Christiansen, Philip Freeman, Svend Eggert Jensen, Charlotte Schmidt Skov, Ahmed Aziz, Henrik Steen Hansen, Julia Ellert, Karsten Tange Veien, Knud Erik Pedersen, Knud Hansen, Ole Ahlehoff, Helle Cappelen, Daniel Wittrock, Poul Anders Hansen, Jens Peter Ankersen, Kim Witting Hedegaard, John Kempel, Henning Kaus, Dennis Erntgaard, Danny Mejsner Pedersen, Matthias Giebner, Troels Martin Hansen, Mina Radovanović, Maja Prodanović, Lidija Savić, Marijana Pejic, Dragan Matić, Ana Ušćumlić, Ida Subotić, Ratko Lasica, Vladan Vukcevic, Alfonso Suárez, Beatriz Samaniego ほか 487 名 - The Lancet 2019 被引用: 324

  5. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Colm G. Hanratty, Indulis Kumsārs, Pēteris Stradiņš, Terje K. Steigen, Ole Fröbert, Alastair N.J. Graham, Petter Cappelen Endresen, Matthias Corbascio, Olli A. Kajander, Uday Trivedi, Juha Hartikainen, Vesa Anttila, David Hildick‐Smith, Leif Thuesen, Evald Høj Christiansen - The Lancet 2016 被引用: 773

  6. Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul W. Armstrong, Elliott M. Antman, Keith A.A. Fox, C Hamm, E. Magnus Ohman, Maarten L. Simoons, Global Perspective Group, P A Poole-Wilson, Enrique Gurfinkel, J L López-Sendón, Priya Pais, Shanthi Mendis, Jiaying Zhu, Implementation Group, Lars Wallentin, Francisco Fernández‐Avilés, K M Fox, А. Н. Пархоменко, S. G. Priori, Michał Tendera, L M Voipio-Pulkki, A. Vahanian, A. J. Camm, Raffaele De Caterina, V. Dean, Kenneth Dickstein, G. Filippatos, Christian Funck‐Brentano, Irene Hellemans, Salome Kristensen, K. McGregor, Udo Sechtem, Sigmund Silber, Michał Tendera, P. Widimsky, José Luis Zamorano, Document Reviewers, João Morais, S. Brener, Robert A. Harrington, David A. Morrow, Udo Sechtem, Mervyn Jun Rui Lim, Marco Antonio Martínez‐Ríos, Steven R. Steinhubl, Gregory N. Levine, W. Brian Gibler, David C. Goff, M. Tubaro, D Dudek, Nawwar Al‐Attar - European Heart Journal 2007 被引用: 2,531

  7. Effect of Ischemic Postconditioning During Primary Percutaneous Coronary Intervention for Patients With ST-Segment Elevation Myocardial Infarction

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacob Lønborg, Lars Køber, for the Third Danish Study of Optimal Acute Treatment of Patients With ST Elevation Myocardial Infarction–Ischemic Postconditioning (DANAMI-3–iPOST) Investigators - JAMA Cardiology 2017 被引用: 128

  8. Deferred versus conventional stent implantation in patients with ST-segment elevation myocardial infarction (DANAMI 3-DEFER): an open-label, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2016 被引用: 206

  9. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes

    著者: , , , , , , , , - Circulation 2007 被引用: 611

  10. Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Iwar Sjögren, Stefan James, Heikki Miettinen, Jens Flensted Lassen, Leif Thuesen - Circulation 2010 被引用: 305

  11. Distance to invasive heart centre, performance of acute coronary angiography, and angioplasty and associated outcome in out-of-hospital cardiac arrest: a nationwide study

    著者: , , , , , , , , , , , , - European Heart Journal 2017 被引用: 99

  12. Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2006 被引用: 725

  13. Acute coronary angiography in patients resuscitated from out-of-hospital cardiac arrest—A systematic review and meta-analysis

    著者: , - Resuscitation 2012 被引用: 159

  14. Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study

    著者: , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2016 被引用: 125

  15. It’s Time for a Change to a Troponin Standard

    著者: , , , , , , - Circulation 2000 被引用: 655

  16. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial

    著者: , , , , , , , , , , , , , , , , - The Lancet 2013 被引用: 203

  17. Long-Term Results After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2013 被引用: 178

  18. Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention

    著者: , , , , , , , , , , , , , , , , , , , , , - Circulation Cardiovascular Interventions 2016 被引用: 128

  19. The Prognostic Value of Serum Troponin T in Unstable Angina

    著者: , , , , , , , - New England Journal of Medicine 1992 被引用: 965

  20. Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents

    著者: , , , , , , , , , , , , - Journal of the American College of Cardiology 2016 被引用: 131

  21. Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch: the Nordic-Baltic Bifurcation Study IV

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jens Flensted Lassen - Open Heart 2020 被引用: 63

  22. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2010 被引用: 211

  23. Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial

    著者: , , , , , , , , , , , , , , , , , , - The Lancet 2014 被引用: 114

  24. Evaluation of Imprecision for Cardiac Troponin Assays at Low-Range Concentrations

    著者: , , , , , , , , - Clinical Chemistry 2004 被引用: 369